Globin gene deletion in HPFH, δ°β° thalassaemia and Hb Lepore disease

Sergio Ottolenghi(University of Milano-Bicocca), Giuseppe Masera(Azienda Ospedaliera San Gerardo), Clemenceau Acquaye(Kumasi Technical University), E. Polli(University of Milan), Alessandro M. Gianni(University of Milan), Barbára Giglioni, J.H. Oldham(Kumasi Technical University), Paola Comi(University of Milan)

Nature

April 1, 1979

10.1038/278654a0

Cited by 77

Related Papers

Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

|New England Journal of Medicine|2000|598

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

|Journal of Clinical Oncology|2010|167

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

|The Lancet Oncology|2012|145

Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells

|Biochemical Pharmacology|2007|118